231 related articles for article (PubMed ID: 22369253)
1. NPY modulates PYY function in the regulation of energy balance and glucose homeostasis.
Zhang L; Nguyen AD; Lee IC; Yulyaningsih E; Riepler SJ; Stehrer B; Enriquez RF; Lin S; Shi YC; Baldock PA; Sainsbury A; Herzog H
Diabetes Obes Metab; 2012 Aug; 14(8):727-36. PubMed ID: 22369253
[TBL] [Abstract][Full Text] [Related]
2. Adult-onset PYY overexpression in mice reduces food intake and increases lipogenic capacity.
Shi YC; Hämmerle CM; Lee IC; Turner N; Nguyen AD; Riepler SJ; Lin S; Sainsbury A; Herzog H; Zhang L
Neuropeptides; 2012 Aug; 46(4):173-82. PubMed ID: 22575886
[TBL] [Abstract][Full Text] [Related]
3. PYY transgenic mice are protected against diet-induced and genetic obesity.
Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A
Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants.
Kirchner H; Tong J; Tschöp MH; Pfluger PT
Am J Physiol Endocrinol Metab; 2010 May; 298(5):E909-19. PubMed ID: 20179246
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y and peptide YY protect from weight loss caused by Bacille Calmette-Guérin in mice.
Painsipp E; Köfer MJ; Farzi A; Dischinger US; Sinner F; Herzog H; Holzer P
Br J Pharmacol; 2013 Nov; 170(5):1014-26. PubMed ID: 23992467
[TBL] [Abstract][Full Text] [Related]
6. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
Riediger T; Bothe C; Becskei C; Lutz TA
Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
[TBL] [Abstract][Full Text] [Related]
7. Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner.
Edelsbrunner ME; Herzog H; Holzer P
Behav Brain Res; 2009 Oct; 203(1):97-107. PubMed ID: 19397935
[TBL] [Abstract][Full Text] [Related]
8. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
van den Hoek AM; Heijboer AC; Voshol PJ; Havekes LM; Romijn JA; Corssmit EP; Pijl H
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E238-45. PubMed ID: 16940471
[TBL] [Abstract][Full Text] [Related]
9. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
10. Duplication of neuropeptide Y and peptide YY in Nile tilapia Oreochromis niloticus and their roles in food intake regulation.
Yan P; Jia J; Yang G; Wang D; Sun C; Li W
Peptides; 2017 Feb; 88():97-105. PubMed ID: 27988351
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y mediates the short-term hypometabolic effect of estrogen deficiency in mice.
Zengin A; Nguyen AD; Wong IP; Zhang L; Enriquez RF; Eisman JA; Herzog H; Baldock PA; Sainsbury A
Int J Obes (Lond); 2013 Mar; 37(3):390-8. PubMed ID: 22565420
[TBL] [Abstract][Full Text] [Related]
12. Regulation of energy homeostasis by the NPY system.
Loh K; Herzog H; Shi YC
Trends Endocrinol Metab; 2015 Mar; 26(3):125-35. PubMed ID: 25662369
[TBL] [Abstract][Full Text] [Related]
13. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler SJ; Stehrer B; Yulyaningsih E; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A
Diabetes Obes Metab; 2010 Jul; 12(7):591-603. PubMed ID: 20590734
[TBL] [Abstract][Full Text] [Related]
14. Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice.
Nakajima M; Inui A; Teranishi A; Miura M; Hirosue Y; Okita M; Himori N; Baba S; Kasuga M
J Pharmacol Exp Ther; 1994 Feb; 268(2):1010-4. PubMed ID: 8113957
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
Park S; Peng XD; Frohman LA; Kineman RD
Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
[TBL] [Abstract][Full Text] [Related]
16. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice.
Patel HR; Qi Y; Hawkins EJ; Hileman SM; Elmquist JK; Imai Y; Ahima RS
Diabetes; 2006 Nov; 55(11):3091-8. PubMed ID: 17065347
[TBL] [Abstract][Full Text] [Related]
18. Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesity.
Shi YC; Lin S; Castillo L; Aljanova A; Enriquez RF; Nguyen AD; Baldock PA; Zhang L; Bijker MS; Macia L; Yulyaningsih E; Zhang H; Lau J; Sainsbury A; Herzog H
Obesity (Silver Spring); 2011 Nov; 19(11):2137-48. PubMed ID: 21546930
[TBL] [Abstract][Full Text] [Related]
19. Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y₁ and Y₂ receptors.
Tough IR; Forbes S; Tolhurst R; Ellis M; Herzog H; Bornstein JC; Cox HM
Br J Pharmacol; 2011 Sep; 164(2b):471-84. PubMed ID: 21457230
[TBL] [Abstract][Full Text] [Related]
20. NPY and Y receptors: lessons from transgenic and knockout models.
Lin S; Boey D; Herzog H
Neuropeptides; 2004 Aug; 38(4):189-200. PubMed ID: 15337371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
